Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1E274DOI Listing

Publication Analysis

Top Keywords

progression myelodysplasia
4
myelodysplasia low-dose
4
low-dose methotrexate
4
methotrexate therapy
4
therapy rheumatoid
4
rheumatoid arthritis
4
progression
1
low-dose
1
methotrexate
1
therapy
1

Similar Publications

Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review.

Cells

November 2024

Department of Medicine, Division of Internal Medicine, Lausanne University Hospital (CHUV), University of Lausanne, 1005 Lausanne, Switzerland.

VEXAS syndrome, a monogenic X-linked disorder resulting from mutations in the UBA1 gene, has emerged as a key model for unraveling the links between systemic inflammatory or autoimmune diseases (SIAD) and myelodysplastic syndromes (MD). This syndrome is characterized by the presence of vacuoles, X-linked inheritance, autoinflammation, and somatic mutation patterns, highlighting a unique intersection between genetic and immunological dysregulation. Apart from VEXAS, 10% to 30% of individuals diagnosed with MDS exhibit SIAD phenotypes, a significant increase compared to the 5% incidence in the general population.

View Article and Find Full Text PDF

Background: Mucormycosis is a highly lethal opportunistic fungal disease caused by ubiquitous molds of the order Mucorales, with Rhizopus, Lichtheimia and Mucor being the most common genera. This rare disease primarily affects immunocompromised patients, with presentations ranging from rhino-orbito-cerebral infections to disseminated mucormycosis with angioinvasion, leading to thrombosis and tissue infarction. Gastrointestinal mucormycosis is the least common clinical presentation and is believed to be secondary to spore ingestion.

View Article and Find Full Text PDF

[Clinical Analysis of CD4CD8 T-Cell Large Granular Lymphocytic[JP] Leukemia].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

October 2024

Department of Hematology, Linquan People's Hospital, Linquan 236400, Anhui Province, China.

Article Synopsis
  • The study investigates the clinical features and treatment of a rare condition called CD4CD8 T-cell large granular lymphocytic leukemia (T-LGLL) through a case report.
  • A 70-year-old woman was diagnosed and exhibited symptoms like low platelet counts and myelodysplasia, with blood tests showing an abundance of large granular lymphocytes.
  • Treatment involving cyclophosphamide and prednisone led to partial remission, highlighting the unique clinical characteristics of CD4CD8 T-LGLL compared to other forms.
View Article and Find Full Text PDF

[Diagnosis and Risk Stratification of Acute Myeloid Leukemia, Myelodysplasia -Related].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

October 2024

Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.

Objective: To analyze the clinical and genetic characteristics of acute myeloid leukemia, myelodysplasia-related (AML-MR) patients and evaluate their prognostic risk stratification, to guide clinical treatment decisions and improve understanding of the biological characteristics and disease progression.

Methods: The study analyzed cellular and molecular genetic information of 307 AML-MR patients, diagnosed based on clinical history, bone marrow morphology, cytogenetics, and molecular genetic abnormalities. The risk stratification followed the 2022 ELN guidelines.

View Article and Find Full Text PDF
Article Synopsis
  • SAMD9 and SAMD9L are genes linked to antiviral functions that affect cell growth and can lead to diverse health issues when mutated, including immune problems and bone marrow failure.
  • Most patients with these mutations experience a range of symptoms, with SAMD9 often associated with growth issues and adrenal insufficiency, while SAMD9L may lead to progressive neurological problems.
  • The study compiles data from 243 cases, emphasizing the need for better understanding and management of these syndromes through genetic testing and specialized care to improve patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!